Sequent Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Sequent Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,000	Closed	-$367K	–	73
2021 Q2	$367K	Sell	2,000 -2,000	-50%	-$343K	0.21%	55
2021 Q1	$612K	Sell	4,000 -4,000	-50%	-$619K	0.38%	41
2020 Q4	$1.25M	Hold	8,000	–	–	0.82%	23
2020 Q3	$915K	Hold	8,000	–	–	0.66%	33
2020 Q2	$898K	Hold	8,000	–	–	0.68%	32
2020 Q1	$718K	Hold	8,000	–	–	0.59%	38
2019 Q4	$865K	Hold	8,000	–	–	0.5%	35
2019 Q3	$784K	Hold	8,000	–	–	0.57%	30
2019 Q2	$1.05M	Buy	8,000 +2,000	+33%	+$258K	0.76%	26
2019 Q1	$811K	Buy	+6,000	New	+$746K	0.58%	26
2018 Q4	–	Sell	-5,000	Closed	-$695K	–	60
2018 Q3	$695K	Hold	5,000	–	–	0.48%	32
2018 Q2	$621K	Hold	5,000	–	–	0.43%	33
2018 Q1	$606K	Hold	5,000	–	–	0.36%	45
2017 Q4	$598K	Hold	5,000	–	–	0.33%	48
2017 Q3	$701K	Hold	5,000	–	–	0.41%	39
2017 Q2	$608K	Hold	5,000	–	–	0.37%	43
2017 Q1	$606K	Buy	+5,000	New	+$645K	0.34%	45
2016 Q4	–	Sell	-5,000	Closed	-$613K	–	57
2016 Q3	$613K	Hold	5,000	–	–	0.39%	38
2016 Q2	$584K	Hold	5,000	–	–	0.39%	40
2016 Q1	$696K	Hold	5,000	–	–	0.48%	39
2015 Q4	$954K	Hold	5,000	–	–	0.7%	32
2015 Q3	$782K	Buy	5,000 +955	+24%	+$174K	0.59%	39
2015 Q2	$731K	Buy	4,045 +679	+20%	+$117K	0.51%	48
2015 Q1	$583K	Buy	3,366 +895	+36%	+$162K	0.42%	51
2014 Q4	$457K	Hold	2,471	–	–	0.33%	48
2014 Q3	$410K	Hold	2,471	–	–	0.31%	50
2014 Q2	$386K	Hold	2,471	–	–	0.28%	51
2014 Q1	$376K	Buy	+2,471	New	+$393K	0.3%	47

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Sequent Asset Management's ALXN Position: Q3 2021 in Review

Sequent Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,000 shares — an estimated $367K sold.

Sequent Asset Management first reported a position in ALXN in Q1 2014 and held it in 28 quarters. The position peaked at $1.25M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Sequent Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Sequent Asset Management sold 2,000 Alexion Pharmaceuticals shares in Q3 2021, an estimated $367K.
Sequent Asset Management first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 28 quarters.
Sequent Asset Management's Alexion Pharmaceuticals position peaked at $1.25M in Q4 2020.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Sequent Asset Management's 13F filing for Q3 2021, filed 15 Oct 2021.